Tag Archives: European Union

EMA Sets Budget and Priorities for 2014, Promotes Transparency

In a bid to improve transparency in 2014, the European Medical Agency’s December Management Board Meeting cleared the way for the publication of the agendas and minutes of the Agency’s Committee for Medicinal Products for Human Use (CHMP), Committee for Medicinal Products for Veterinary Use (CVMP) and Committee for Advanced Therapies (CAT). This week the EMA […]
Posted in Europe, Global, Regulatory | Also tagged , , , | Leave a comment

Europe's Mooted 'Passport for Physicians': Implications for Patients

Europe moved one step closer to a passport for physicians in early October. The European Parliament gave its backing to creating a virtual professional qualifications card that will allow doctors, pharmacists, and other professionals to practice in another EU country. The system also envisages an alert system, so that health professionals barred in one country […]
Posted in Europe, Global, Guest Blog, Strategy | Also tagged , , , , | Leave a comment

Who Dares to Stop the European Transparency Bandwagon?

Who is Trying to Stop the European Transparency Bandwagon? Reflector, EPE, October 14 2013 The data-transparency bandwagon is rolling rapidly across Europe, energetically propelled by regulators, health campaigners, and generic manufacturers. Much of the research-based industry is stepping out of the way of what looks like an unstoppable juggernaut, hoping at best to nudge it […]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , | Leave a comment

Europe: Still An Attractive Place for Clinical Trials?

At the end of this month, the European Medicines Agency will close the consultation on its draft policy on Publication and access to clinical-trial data. The aim of the policy is laudable: to open up as much information as possible into the public domain with the aim of stimulating new avenues of research. So far […]
Posted in Europe, Op-Ed, R&D | Also tagged , , , | 1 Comment

Europe: New Device and Diagnostics Legislation Could Shake Up the Drug Industry

EuropeNew Device and Diagnostics Legislation Will Shake Up Drug Industry The shockwaves from the current European Union debates in Brussels on medical devices are are likely to echo through the medicines business over the next few years. This month, the European parliament’s health committee will reach its view on the two major proposals launched last […]
Posted in Europe, Op-Ed, Regulatory | Also tagged , , , | 1 Comment
  • Categories

  • Meta